Types of weight loss medications: an adult's guide to safe options

Choosing the right medication from the expanding landscape of types of weight loss medications is genuinely difficult. The market has grown from a handful of options to a spectrum of drugs with very different mechanisms, side effect profiles, and long-term expectations. Some work in your gut. Others rewire appetite signals in your brain. The newest class mimics hormones your body already produces. This guide breaks down every major category, what the evidence actually shows, and the criteria that should drive any serious conversation with a physician about your options.

Table of Contents

• How to evaluate weight loss medications: key criteria
• Orlistat: gut-based weight loss with minimal systemic effects
• Non-GLP-1 drugs: targeting appetite and cravings with phentermine-topiramate and naltrexone-bupropion
• GLP-1 receptor agonists and dual agonists: the modern incretin-based agents
• Comparison of FDA-approved weight loss medications
• Our perspective: the medication is not the whole strategy
• Ready to find the right medication for your goals?
• Frequently asked questions

Key Takeaways

How to evaluate weight loss medications: key criteria

Before comparing specific drugs, you need a framework. Not every medication works for every person, and the "best weight loss medications" conversation is really a matching exercise between your biology, lifestyle, and medical history.

Here are the factors that matter most when reviewing any weight loss medication option:

• Effectiveness: Look at average weight loss in clinical trials, not just maximum results. A drug that helps 80% of patients lose 10% of body weight is often more useful than one that helps 20% lose 25%.
• Safety profile: Side effects range from mild gastrointestinal discomfort to cardiovascular risks. Contraindications matter too, especially if you have thyroid disease, a history of eating disorders, or cardiovascular conditions.
• Method of administration: Daily pills, weekly injections, and twice-daily tablets all affect adherence differently. A weekly injection is often easier to maintain than remembering three pills a day.
• Age and indication approvals: Some medications are FDA-approved only for adults; others extend to adolescents aged 12 and up. This matters if you're researching options for a younger family member.
• Cost and insurance coverage: GLP-1 receptor agonists can cost over $1,000 per month without insurance. Older options like orlistat are far cheaper, especially in over-the-counter form.
• Your lifestyle and preferences: A patient with a history of anxiety may want to avoid stimulant-adjacent medications. Someone who travels frequently may prefer a weekly injection over a thrice-daily pill.

Medically supervised weight loss through a physician ensures these criteria are applied to your specific case rather than a generic protocol. With these criteria in mind, we can explore the main categories of weight loss medications available today.

Orlistat: gut-based weight loss with minimal systemic effects

Orlistat is one of the oldest FDA-approved weight loss drugs and the only one that works entirely within the digestive tract. It does not cross into the bloodstream in any meaningful amount, which makes it fundamentally different from every other option on this list.

Orlistat works locally in the gut to reduce fat absorption with minimal systemic effects, making it suitable for patients avoiding systemic medications. Specifically, it inhibits pancreatic lipase, the enzyme responsible for breaking down dietary fat. Undigested fat passes through the body rather than being absorbed, reducing caloric intake from fat by roughly 30%.

Key points about orlistat:

• Dosing: Taken three times daily with fat-containing meals. A lower-dose version (Alli) is available over the counter; the prescription-strength version (Xenical) is roughly double the dose.
• Side effects: Almost entirely gastrointestinal. Oily stools, increased flatulence, and urgent bowel movements are common, especially if you eat a high-fat meal. These side effects are uncomfortable but not dangerous.
• Nutritional considerations: Because fat absorption is reduced, fat-soluble vitamins (A, D, E, and K) are also absorbed less efficiently. A daily multivitamin taken two hours before or after the dose is standard practice.
• Who it fits: Patients who want to avoid any neurological or systemic drug effects, those with cardiovascular concerns that rule out stimulant-adjacent medications, and people who prefer an over-the-counter weight loss med with a long safety record.

Pro Tip: Combining orlistat with a genuinely low-fat diet (under 30% of calories from fat) does two things: it maximizes the drug's effectiveness and dramatically reduces the gastrointestinal side effects. The side effects are essentially a real-time signal that you ate too much fat.

Next are medications targeting the brain's appetite and reward systems for a different therapeutic approach.

Non-GLP-1 drugs: targeting appetite and cravings with phentermine-topiramate and naltrexone-bupropion

These two combination drugs represent a different philosophy. Rather than working in the gut or mimicking hormones, they act on the central nervous system to reduce how much you want to eat and how rewarding food feels.

Older non-GLP-1 drugs like naltrexone-bupropion target brain reward pathways to curb cravings, suitable for patients with mood issues or food addiction. Here is how each works:

• Phentermine-topiramate (Qsymia): Phentermine is a stimulant that suppresses appetite; topiramate is an anticonvulsant that independently reduces appetite through mechanisms that are not fully understood. Together, they produce average weight loss of around 8 to 10% of body weight. Taken once daily in the morning.
• Naltrexone-bupropion (Contrave): Naltrexone blocks opioid receptors involved in food reward; bupropion is an antidepressant that reduces appetite. This combination is particularly useful for patients who describe eating as emotionally driven or compulsive. Taken one to two times daily.
• Who benefits most: Patients who identify strong cravings, emotional eating, or a history of using food as a mood regulator often respond better to phentermine-topiramate and Contrave than to gut-based options.
• Monitoring requirements: Blood pressure, heart rate, and mood should be tracked regularly. Phentermine has stimulant properties that can elevate blood pressure. Bupropion carries an FDA black box warning for increased suicidal thoughts in younger patients, though this is primarily relevant in the antidepressant context.

Pro Tip: These medications require monitoring for side effects like mood changes or blood pressure elevation, especially in the first 8 to 12 weeks. Don't skip follow-up appointments during dose escalation.

More recently developed incretin hormone mimetics have changed weight loss therapy with even greater results.

GLP-1 receptor agonists and dual agonists: the modern incretin-based agents

This is the class that has reshaped obesity medicine. GLP-1 (glucagon-like peptide-1) receptor agonists mimic a gut hormone that regulates appetite, slows stomach emptying, and reduces overall food intake. They don't just suppress hunger; they appear to recalibrate the body's set point for how much food feels satisfying.

Liraglutide, semaglutide, and tirzepatide mimic incretin hormones to reduce appetite and slow gastric emptying, leading to significant weight loss. Here's how the three major options compare within this class:

• Liraglutide (Saxenda): A daily subcutaneous injection approved for adults and adolescents aged 12 and up. Produces average weight loss of 5 to 8%. It was the first GLP-1 RA approved specifically for weight management rather than diabetes.
• Semaglutide (Wegovy): Available as a weekly injection and, more recently, as a daily oral pill. Also approved for ages 12 and up. Produces average weight loss of around 14.9% in clinical trials, a meaningful step up from liraglutide.
• Tirzepatide (Zepbound): A weekly injection that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, making it a dual agonist. Tirzepatide achieves up to 22.5% body weight loss, outperforming semaglutide's 14.9%. This is the highest average efficacy of any approved weight loss medication.

GLP-1 receptor agonists overview and their mechanisms are worth understanding before starting treatment, because there is one critical reality about this class: stopping GLP-1 medications after weight loss typically causes regain due to metabolic adaptation. These are not short-term interventions. They function best as chronic therapies, similar to how blood pressure medication is taken indefinitely rather than stopped once numbers normalize.

Pro Tip: Monthly follow-ups during dose escalation with tirzepatide in particular can help your physician adjust the pace of increases, which significantly reduces nausea and GI discomfort during the first few months.

To help you visualize differences, here is a comparison table summarizing key weight loss medications.

Comparison of FDA-approved weight loss medications

The FDA has approved six prescription medications for long-term chronic weight management in adults, with different dosing, mechanisms, and age indications. The table below covers the major weight loss medication options currently available.

This table is a starting point for conversation with a physician, not a prescription guide. The right choice depends on your metabolic profile, medical history, and what you can realistically sustain.

With this comparison in mind, let's explore how to decide the best option for your unique situation.

Our perspective: the medication is not the whole strategy

Here is something most coverage of weight loss drugs gets wrong: it treats the medication as the treatment. The medication is a tool. The treatment is the system around it.

We have seen patients achieve remarkable results with tirzepatide who had previously "failed" on semaglutide, not because the drug was better for them biologically, but because the second time around they had structured follow-up, dietary coaching, and realistic expectations about the timeline. Conversely, we have seen patients with excellent early results on GLP-1 medications regain everything within a year of stopping, because no one had prepared them for the fact that these drugs work best as long-term therapies.

The uncomfortable truth about weight loss medications is that they expose how broken the "try it and see" model of prescribing actually is. These are not antibiotics you take for 10 days. They are chronic metabolic interventions that require physician oversight, periodic reassessment, and an honest conversation about what happens if you stop. The patients who do best are the ones who go in with that understanding from day one.

One more thing worth saying: the conversation about over-the-counter weight loss meds and natural weight loss supplements is largely a distraction for anyone with a BMI over 30 or significant metabolic dysfunction. The evidence gap between prescription options and OTC alternatives is not small. It is enormous. That doesn't mean supplements have no role, but it does mean they shouldn't be the first or only tool you reach for when the clinical options are this effective.

Ready to find the right medication for your goals?

If you've been doing your research and you're ready to move from information to action, Grown Up Meds connects you with licensed physicians who specialize in medically supervised weight management. The process starts with a simple online assessment, and from there, a physician reviews your health history and recommends a personalized protocol, whether that's a GLP-1 receptor agonist, a combination medication, or another evidence-based approach.

Medications are shipped from US-based pharmacies directly to your door, with ongoing physician support built into the program. You're not left to figure out dosing adjustments or side effect management on your own. If you're serious about getting results that last, start your assessment today and get matched with a treatment plan designed for your specific biology and goals.

Frequently asked questions

What are the main types of weight loss medications available?

There are three primary categories: gut-based drugs like orlistat, non-GLP-1 brain appetite suppressants like phentermine-topiramate and naltrexone-bupropion, and modern incretin-based GLP-1 receptor agonists including liraglutide, semaglutide, and tirzepatide. The FDA has approved six prescription medications for long-term chronic weight management in adults, each with distinct mechanisms and indications.

How effective are GLP-1 receptor agonists for weight loss?

GLP-1 receptor agonists typically reduce body weight by 5% to over 20%, depending on the specific drug and the individual. Adults taking tirzepatide achieved up to 22.5% average body weight reduction in clinical trials, surpassing semaglutide's 14.9% loss.

Can weight regain after stopping weight loss medications?

Yes, and this is one of the most important things to understand before starting. Stopping GLP-1 medications after weight loss leads to regain because of metabolic adaptation and increased hunger hormones, which is why these drugs are designed for chronic use rather than short-term courses.

Are there weight loss medications approved for children or teens?

Yes, four drugs are approved for adults and children ages 12 and older: orlistat, liraglutide, phentermine-topiramate, and semaglutide, all under medical supervision. Tirzepatide is currently approved for adults only.

Recommended

• Grown Up Meds | Science-Backed Health Optimization